SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Revenue showed a marginal decline at Rs. 1.71 millions. For the quarter ended September 2024, as compared to corresponding quarter of last year.The Net Loss for the quarter ended September 2024 is Rs. -3.05 millions as compared to Net Loss of Rs. -0.28 millions of corresponding quarter ended September 2023 Operating profit Margin for the quarter ended September 2024 further decreased to -3.02% as compared to -0.26% of corresponding quarter ended September 2023


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202409 202309 % Var 202409 202309 % Var 202403 202303 % Var
Sales 1.71 0.00 0.00 2.75 0.00 0.00 0.00 0.00 0.00
Other Income 0.00 0.00 0.00 0.30 0.50 -40.00 1.99 4.19 -52.51
PBIDT -3.02 -0.26 1061.54 -2.90 -0.06 4733.33 0.95 2.34 -59.40
Interest 0.01 0.00 0.00 0.01 0.00 0.00 0.00 0.00 0.00
PBDT -3.03 -0.26 1065.38 -2.91 -0.06 4750.00 0.95 2.34 -59.40
Depreciation 0.02 0.02 0.00 0.04 0.04 0.00 0.07 0.08 -12.50
PBT -3.05 -0.28 989.29 -2.95 -0.10 2850.00 0.88 2.26 -61.06
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.22 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT -3.05 -0.28 989.29 -2.95 -0.10 2850.00 0.66 2.26 -70.80
Equity 52.39 52.39 0.00 52.39 52.39 0.00 52.39 52.39 0.00
PBIDTM(%) -176.61 0.00 0.00 -105.45 0.00 0.00 0.00 0.00 0.00

Venmax Drugs&Pharma Share Price

24.66 1.07 (4.54%)
16-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1693.15
Dr. Reddys Lab 1221.25
Cipla 1230.75
Zydus Lifesciences 939.20
Lupin 2326.50
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×